Dr. Elisabeth Eppard is a radiochemist working on the development and process implementation of new compounds for theranostic application. In 2013 she obtained her Ph.D. under Prof. Rösch at the Institute of Nuclear Chemistry, Johannes Gutenberg University Mainz, Germany, where she worked on radiometal-based radiopharmaceuticals. After four years as a junior research group leader in the Department of Nuclear Medicine, University Hospital Bonn, Germany, Dr. Eppard joined Positronpharma SA, Santiago, Chile, as a senior scientist in 2018. There she was responsible for research and clinical applications based on 68Ga-, 44Sc-, and 177Lu-labelled theranostics. Since 2021, she has been a radiochemist in the Department of Nuclear Medicine, University Hospital Magdeburg, Germany, where she is continuing her research.